Atika Capital Management »

Protagonist Therapeutics shares owned by Atika Capital Management

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Atika Capital Management from 13F filings

Historical chart of Atika Capital Management investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by Atika Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by Atika Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $7.5M 86k 87.34
2025-09-30 $5.5M 83k 66.43

More positions owned by Atika Capital Management

Robinhood Mkts Com Cl A Put Option (HOOD)
Spdr Series Trust State Street Spd Put Option (XBI)
Vertiv Holdings Com Cl A (VRT)
Eli Lilly & Co. (LLY)
Intuitive Surgical Com New (ISRG)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Shopify Cl A Sub Vtg Shs (SHOP)
Madrigal Pharmaceuticals (MDGL)
Bwx Technologies (BWXT)
Amazon (AMZN)
Cogent Biosciences (COGT)
Netflix (NFLX)
Talen Energy Corp (TLN)
Seagate Technology Hldngs Ord Shs (STX)

View all positions for Atika Capital Management

Top funds holding Protagonist Therapeutics

BlackRock
Farallon Capital Management
Vanguard Group
Rtw Investments
State Street Corporation
UBS Group
BVF
Johnson & Johnson
Wellington Management Company
Invesco
Geode Capital Management
Woodline Partners
Driehaus Capital Management
Henderson Group
ADAR1 Capital Management

View all funds holding Protagonist Therapeutics